There are several independent reports that have shown that mutations or polymorphisms in the human MDR2 homologue are associated with different entities of cholestatic liver disease in patients[26,209,210], which in turn underlines the benefit of animal models for clinical fibrosis research. The gene discussed is ABCB4; the disease is Cholestatic liver disease.